MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3

MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3

Vascular endothelial growth factor (VEGF) signaling plays a critical role in the carcinogenesis and tumor development of several cancer types. However, its pathological significance in prostate cancer, one of the most frequent and lethal malignancies in men, remains unclear. In the present study, we...

Full description

Bibliographic Details
Main Authors: Aya Yamamura, Md Junayed Nayeem, Hiroyuki Muramatsu, Kogenta Nakamura, Motohiko Sato
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
MAZ51
PC-3
prostate cancer
vascular endothelial growth factor
VEGF-C
VEGFR-3
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.667474/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.667474/full

Similar Items